A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers

NCT05941247 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Hemay005 60 mg

Sponsor

Ganzhou Hemay Pharmaceutical Co., Ltd

Collaborators

[object Object]